QYR Market Research Global Peptide Therapeutics market research | Page 5

QYResearch
The classification of Peptide Therapeutics includes Injection,
Oral and other, and the proportion of Injection in 2017 is about
74.2%, and the proportion is decreasing trend from 2013 to 2018.
Peptide Therapeutics is widely sales for Cancer, Metabolic
Disorders, Central Nervous System and Others. The key
application of peptide therapeutics is into cancer mainly used for
treating prostrate, pancreatic, ovarian, and breast cancer. and
the consumption proportion is about 33.6% in 2017.
www.qyresearch.com